Reducing gastric secretions-a role for histamine 2 antagonists or proton pump inhibitors in malignant bowel obstruction?

Supportive Care in Cancer

Volumn 17, Issue 12, 2009, Pages 1463-1468

  Clark, K ^a,b   Lam, L ^b   Currow, D ^c,d  

^a Cunningham Centre for Palliative Care   (Australia)

^b UNIVERSITY OF NOTRE DAME   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

^d Institute for Palliative and Supportive Care Research   (Australia)

Author keywords

Gastric secretions; Histamine 2 antagonists; Proton pump inhibitors

Indexed keywords

FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LAFUTIDINE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; GASTRIC SUCTION; HUMAN; INTESTINE OBSTRUCTION; MALIGNANT BOWEL OBSTRUCTION; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH JUICE; STOMACH SECRETION; SYSTEMATIC REVIEW;

ANTI-ULCER AGENTS; CLINICAL TRIALS AS TOPIC; GASTRIC JUICE; HISTAMINE H2 ANTAGONISTS; HUMANS; INTESTINAL OBSTRUCTION; NEOPLASMS; PROGNOSIS; PROTON PUMP INHIBITORS; RANITIDINE; VOMITING;

EID: 71349085145     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-009-0609-3     Document Type: Article

References (27)

1. Feuer DJ, Broadley KE, Shepherd JH, Barton DP (2000) Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev (4):CD002764
2. CR Pameijer DM Mahvi JA Stewart SM Weber 2005 Bowel obstruction in patients with metastatic cancer: does intervention influence outcome? Int J Gastrointest Cancer 35 2 127 133 10.1385/IJGC:35:2:127 10.1385/IJGC:35:2:127 15879627
3. C Ripamonti E Bruera 2002 Palliative management of malignant bowel obstruction Int J Gynecol Cancer 12 2 135 143 10.1046/j.1525-1438.2002.01103.x 10.1046/j.1525-1438.2002.01103.x 11975672 (Pubitemid 34477875)
4. Australian Therapeutic Guidelines Palliative Care 2nd ed. Melbourne, Australia: Therapeutic Guidelines Limited; 2005
5. Ouellette J, Patterson L, P. T. Fast Fact and Concept #091: Interventional Options for Malignant Upper GI Obstruction. American Academy of Hospice and Palliative Care, ( www.epercmcw.edu ), 2007.
6. Clark K, Lam L, Gibson S, Currow D (2009) The effect of ranitidine versus proton pump inhibitors on gastric secretions: a meta-analysis of randomised control trials. Anaesthesia (in press).
7. AR Jadad RA Moore D Carroll C Jenkinson DJ Reynolds DJ Gavaghan, et al. 1996 Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1 1 12 10.1016/0197-2456(95) 00134-4 10.1016/0197-2456(95)00134-4 1:STN:280:DyaK28zgvVCmug%3D%3D 8721797
8. Begg CB (1994) Publication Bias. Russell Sage Foundation, New York City
9. M Egger G Davey Smith M Schneider C Minder 1997 Bias in meta-analysis detected by a simple, graphical test BMJ 315 7109 629 634 1:STN:280: DyaK2svls1KjtA%3D%3D 9310563
10. st ed. Melbourne, Australia: Therapeutic Guidelines Limited; 2008
11. RS Krouse 2007 The international conference on malignant bowel obstruction: a meeting of the minds to advance palliative care research J Pain Symptom Manage 34 1 Suppl S1 S6 10.1016/j.jpainsymman.2007.04.005 10.1016/j.jpainsymman.2007.04.005 17544251 (Pubitemid 46962955)
12. T Anthony T Baron S Mercadante S Green D Chi J Cunningham, et al. 2007 Report of the clinical protocol committee: development of randomized trials for malignant bowel obstruction J Pain Symptom Manage 34 1 Suppl S49 S59 10.1016/j.jpainsymman.2007.04.011 10.1016/j.jpainsymman.2007.04.011 17544243 (Pubitemid 46970817)
13. CI Ripamonti AM Easson H Gerdes 2008 Management of malignant bowel obstruction Eur J Cancer 44 8 1105 1115 10.1016/j.ejca.2008.02.028 10.1016/j.ejca.2008.02.028 18359221
14. C Ripamonti R Twycross M Baines F Bozzetti S Capri F De Conno, et al. 2001 Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer Support Care Cancer 9 4 223 233 10.1007/s005200000198 10.1007/s005200000198 1:STN:280:DC%2BD38%2Fhs1Kiuw%3D%3D 11430417 (Pubitemid 32537280)
15. MR Salem AY Wong M Mani EJ Bennett T Toyama 1976 Premedicant drugs and gastric juice pH and volume in paediatric patients Anesthesiology 44 3 216 219 10.1097/00000542-197603000-00010 10.1097/00000542-197603000-00010 1:STN:280:DyaE283gsVSnsg%3D%3D 5924
16. JG Hatlebakk A Berstad 1996 Gastro-oesophageal reflux during 3 months of therapy with ranitidine in reflux oesophagitis Scand J Gastroenterol 31 10 954 958 10.3109/00365529609003113 10.3109/00365529609003113 1:CAS:528: DyaK28XmtlOgtbo%3D 8898414
17. JR Pisegna 2001 Switching between intravenous and oral pantoprazole J Clin Gastroenterol 32 1 27 32 10.1097/00004836-200101000-00007 10.1097/00004836-200101000-00007 1:STN:280:DC%2BD3M3kt1Kgsw%3D%3D 11154164 (Pubitemid 32038107)
18. R Miller 1984 Pharmacokinetics and bioavailability of ranitidine in humans J Pharm Sci 73 10 1376 1379 10.1002/jps.2600731013 10.1002/jps.2600731013 1:CAS:528:DyaL2cXmt1ajur8%3D 6094785
19. M Agar R Webster J Lacey B Donovan A Walker 2004 The use of subcutaneous omeprazole in the treatment of dyspepsia in palliative care patients J Pain Symptom Manage 28 6 529 531 10.1016/j.jpainsymman.2004.10.005 10.1016/j.jpainsymman.2004.10.005 15589074 (Pubitemid 39626093)
20. MP Davis A Furste 1999 Glycopyrrolate: a useful drug in the palliation of mechanical bowel obstruction J Pain Symptom Manage 18 3 153 154 10.1016/S0885-3924(99) 00063-9 10.1016/S0885-3924(99)00063-9 1:STN:280:DyaK1Mvks1agsw%3D%3D 10517034
21. F Escolano J Castano R Lopez E Bisbe A Alcon 1992 Effects of omeprazole, ranitidine, famotidine and placebo on gastric secretion in patients undergoing elective surgery Br J Anaesth 69 4 404 406 10.1093/bja/69.4.404 10.1093/bja/69.4.404 1:STN:280:DyaK3s%2FktVOqsw%3D%3D 1419452
22. H Hendolin R Suojaranta-Ylinen E Alhava 1993 Effect of single-dose omeprazole and ranitidine on gastric juice acidity and volume in patients undergoing laparotomy Acta Anaesthesiol Scand 37 5 484 487 10.1111/j.1399-6576. 1993.tb03751.x 10.1111/j.1399-6576.1993.tb03751.x 1:STN:280:DyaK3szmt1Cqug%3D%3D 8356861
23. K Nishina K Mikawa N Maekawa Y Takao M Shiga H Obara 1996 A comparison of lansoprazole, omeprazole, and ranitidine for reducing preoperative gastric secretion in adult patients undergoing elective surgery Anesth Analg 82 4 832 836 10.1097/00000539-199604000-00027 10.1097/00000539-199604000-00027 1:CAS:528:DyaK28Xis1Wltrc%3D 8615506 (Pubitemid 26112826)
24. K Nishina K Mikawa Y Takao M Shiga N Maekawa H Obara 2000 A comparison of rabeprazole, lansoprazole, and ranitidine for improving preoperative gastric fluid property in adults undergoing elective surgery Anesth Analg 90 3 717 721 10.1097/00000539-200003000-00038 10.1097/00000539-200003000-00038 1:CAS:528:DC%2BD3cXhvFWnur8%3D 10702463
25. T Uesugi K Mikawa K Nishina O Morikawa Y Takao H Obara 2002 The efficacy of lafutidine in improving preoperative gastric fluid property: a comparison with ranitidine and rabeprazole Anesth Analg 95 1 144 147 10.1097/00000539- 200207000-00025 1:CAS:528:DC%2BD38Xlsl2is7c%3D 12088958
26. D Memis A Turan B Karamanlioglu P Saral M Ture Z Pamukcu 2003 The effect of intravenous pantoprazole and ranitidine for improving preoperative gastric fluid properties in adults undergoing elective surgery Anesth Analg 97 5 1360 1363 1:CAS:528:DC%2BD3sXptlCjtbY%3D 14570652
27. C Goel LK Anand K Gombar 2006 Comparative evaluation of single dose intravenous pantoprazole and ranitidine on gastric pH and volume: a double-blind study J Anaesthesiol Clin Pharmacol 22 2 145 9 1:CAS:528:DC%2BD28Xlt1Slsb0%3D